Gerdes AM - Search Results

1

A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing.

Thomassen M, Pedersen IS, Vogel I, Hansen TV, Brasch-Andersen C, Brasen CL, Crüger D, Sunde L, Nielsen FC, Jensen UB, Bisgaard ML, Borg A, Gerdes AM, Kruse TA. Thomassen M, et al. Among authors: gerdes am. Breast Cancer Res Treat. 2011 Jul;128(1):179-85. doi: 10.1007/s10549-010-1272-6. Epub 2010 Dec 24. Breast Cancer Res Treat. 2011. PMID: 21184276

2

Multipoint linkage analysis in Menkes disease.

Tønnesen T, Petterson A, Kruse TA, Gerdes AM, Horn N. Tønnesen T, et al. Among authors: gerdes am. Am J Hum Genet. 1992 May;50(5):1012-7. Am J Hum Genet. 1992. PMID: 1570830 Free PMC article.

3

Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

Håkansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes AM, Holmberg E, Dahl N, Pandis N, Kristoffersson U, Olsson H, Borg A. Håkansson S, et al. Among authors: gerdes am. Am J Hum Genet. 1997 May;60(5):1068-78. Am J Hum Genet. 1997. PMID: 9150154 Free PMC article.

4

Prognosis and clinical presentation of BRCA2-associated breast cancer.

Loman N, Johannsson O, Bendahl P, Dahl N, Einbeigi Z, Gerdes A, Borg A, Olsson H. Loman N, et al. Eur J Cancer. 2000 Jul;36(11):1365-73. doi: 10.1016/s0959-8049(00)00098-8. Eur J Cancer. 2000. PMID: 10899649

5

Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study.

Høyer AP, Gerdes AM, Jørgensen T, Rank F, Hartvig HB. Høyer AP, et al. Among authors: gerdes am. Breast Cancer Res Treat. 2002 Jan;71(1):59-65. doi: 10.1023/a:1013340327099. Breast Cancer Res Treat. 2002. PMID: 11859874

6

Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation.

Thomassen M, Kruse TA, Olsen KE, Borg A, Gerdes AM. Thomassen M, et al. Among authors: gerdes am. Breast Cancer Res Treat. 2004 Oct;87(3):273-6. doi: 10.1007/s10549-004-9503-3. Breast Cancer Res Treat. 2004. PMID: 15528970

7

'Indirect' BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative.

Cruger DG, Kruse TA, Gerdes AM. Cruger DG, et al. Among authors: gerdes am. Clin Genet. 2005 Sep;68(3):228-33. doi: 10.1111/j.1399-0004.2005.00484.x. Clin Genet. 2005. PMID: 16098011

8

A missense mutation in exon 13 in BRCA2, c.7235G>A, results in skipping of exon 13.

Thomassen M, Kruse TA, Jensen PK, Gerdes AM. Thomassen M, et al. Among authors: gerdes am. Genet Test. 2006 Summer;10(2):116-20. doi: 10.1089/gte.2006.10.116. Genet Test. 2006. PMID: 16792514

9

Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark.

Thomassen M, Gerdes AM, Cruger D, Jensen PK, Kruse TA. Thomassen M, et al. Among authors: gerdes am. Cancer Genet Cytogenet. 2006 Jul 15;168(2):168-71. doi: 10.1016/j.cancergencyto.2005.12.016. Cancer Genet Cytogenet. 2006. PMID: 16843109

10

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.

Thomassen M, Hansen TV, Borg A, Lianee HT, Wikman F, Pedersen IS, Bisgaard ML, Nielsen FC, Kruse TA, Gerdes AM. Thomassen M, et al. Among authors: gerdes am. Acta Oncol. 2008;47(4):772-7. doi: 10.1080/02841860802004974. Acta Oncol. 2008. PMID: 18465347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters